Analysis of the regional pharmaceutical market of hypoglycemic drugs of oral administration

• Main Authors: Orlova T.S., Buyuklinskaya O.V.
• Format: Article in Journal/Newspaper
• Language: Russian
• Published: Saratov State Medical University 2017
• Subjects: glycated hemoglobin; oral hypoglycemic agents; type 2 diabetes; Medicine (General); R5-920; Arkhangelsk
• Online Access: https://doaj.org/article/30e241919182473d8cd2798de60755ef

Aim: to study the regional pharmaceutical market of oral antidiabetic drugs for 2013-2016 according to the example of the pharmacy network of "Yuniver" (Arkhangelsk), not realizing the program of preferential home. Material and Methods. The study was conducted on the basis of reports on the movement of goods in "Yuniver OOO "for the period from 2013 to 2016 were analyzed range of oral antidiabetic drugs on international nonproprietary names, and trade names, dynamic oral antidiabetic drugs sales (number of dispensed packages). Results. On the basis of data on the movement of goods showed an annual expansion of assortment of oral antidiabetic drugs in the pharmacy network, not realizing the program of preferential home. Conclusion. The assortment of oral hypoglycemic preparations on the example of a pharmacy network that does not realize a program of preferential leave for people with diabetes mellitus testifies to the use of modern medicines that prevent the occurrence of microcirculatory disorders of target organs included in the list of vital and essential drugs and in accordance with clinical recommendations on therapy this pathology.